Binding of tissue plasminogen activator to cultured human endothelial cells.
about
The Biology of Annexin A2: From Vascular Fibrinolysis to Innate ImmunityProteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activationAccessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitorNew insights into the role of Plg-RKT in macrophage recruitment.Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbitsalpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.The annexin A2 system and vascular homeostasisHuman tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogenEndothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surfaceHomocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptorLipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines.Thrombin adhesive properties: induction by plasmin and heparan sulfateThe plasminogen receptor, Plg-R(KT), and macrophage functionImmunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells.A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo.Endothelial cell fibrinolytic assembly.The endothelial cell annexin A2 system and vascular fibrinolysis.Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.The search for the ideal thrombolytic agent: maximize the benefit and minimize the risk.Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine.In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase.Binding of tissue plasminogen activator to human aortic endothelial cells.Complex intracellular signal transduction regulates tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type-1 (PAI-1) synthesis in cultured human umbilical vein endothelium.Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activationConversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism.Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation.A recirculatory model for tissue plasminogen activator with saturable endothelial binding.
P2860
Q26795375-B79B1DCF-1D7E-4F9A-8158-BB28E5A726C2Q28591912-96D8A555-EF11-4F32-8227-6FAB3ACEA8A8Q28647054-0B3EF87E-9B83-4CD9-9667-827199CD1C4BQ33768031-2575A5AD-0320-4E84-884E-E3201D73CD59Q33848439-36DC48AE-DB9B-49D2-AE71-8F4254593597Q34125878-D58C0667-3831-48DB-8213-25249267823AQ35028300-C145E48E-603D-45D3-A7B0-630EC341B596Q35593333-55D74633-60E4-41B7-A162-344C4BFFED1DQ35593586-1E80F350-3C44-48C6-A2FB-0D6169B26908Q35612116-2EA09C79-5A62-4DBA-B459-8D8CED05897CQ35799761-7753EDE6-04D9-40E9-B6A4-74F04E7F6798Q36222413-EAB721EC-C7CF-4CD6-9E8C-8AB741956DC5Q36223687-149FCB5C-B65D-4E54-AE20-82A6198B20B9Q36233524-41192684-9658-4201-882F-D489BE50330CQ36357415-960B2BC0-2AD4-4D82-8008-A0E5A4AD55FAQ36529883-C2C91587-6C27-4EEF-A36C-B1D611FCB8FFQ36651337-F1366BAF-5A2E-49B7-A65E-7884852C9A89Q37332176-BBB24674-052D-4554-88D5-1F194758E9ECQ37679552-309555E3-FA90-4E0F-ADC4-58409EBFD8F8Q38340989-6ABD4E2D-23EE-40C3-800C-65E9803D0D69Q38687254-FAD26525-E8F2-4D40-871F-389B4DE7EFFEQ40647353-0D1403C3-A644-4C11-B1B6-EDAFC5E51068Q40766790-0AD96824-2436-4764-9E1C-0726667F98D0Q41041293-2F575438-EB28-426C-BBF7-02AB68E687F2Q41580011-0FF99FE1-9F53-41EF-8D01-237972858788Q41728114-615C08C5-EB87-4132-BC9E-2606466756A7Q42478859-88897326-3F23-4B9B-B3BF-9E2A194191E6Q42595647-9809B427-8C0D-4856-8DB4-63171EC10DF6Q42801672-48EF9ECC-1E10-4F36-84F0-D081E92C483BQ42861747-3575CE5E-42FD-449B-8117-9E133F32F69DQ43551080-2DDF57E7-064C-4219-A632-EA95D7570FA4Q43591840-75D19867-91D1-4051-BE2D-F80F5ED33F7AQ43779011-CAEFBE1A-8710-469D-8C67-0A2E9BAC1493Q46056515-F5F15622-50E3-4BBA-91BB-85373BA42725
P2860
Binding of tissue plasminogen activator to cultured human endothelial cells.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Binding of tissue plasminogen activator to cultured human endothelial cells.
@ast
Binding of tissue plasminogen activator to cultured human endothelial cells.
@en
type
label
Binding of tissue plasminogen activator to cultured human endothelial cells.
@ast
Binding of tissue plasminogen activator to cultured human endothelial cells.
@en
prefLabel
Binding of tissue plasminogen activator to cultured human endothelial cells.
@ast
Binding of tissue plasminogen activator to cultured human endothelial cells.
@en
P2093
P2860
P356
P1476
Binding of tissue plasminogen activator to cultured human endothelial cells.
@en
P2093
K A Hajjar
P C Harpel
R L Nachman
P2860
P304
P356
10.1172/JCI113262
P407
P577
1987-12-01T00:00:00Z